Health
Human trials of Covid-19 vaccine, Covaxin to start at Bhubaneswar from 22 July – Livemint
Healthy volunteers aged between 18 and 55 years having no comorbid conditions or COVID-19 history would be eligible to participate in the clinical trials
Human clinical trials of the India’s indigenously developed coronavirus vaccine is set to begin from tomorrow, 22 July, at a Bhubaneswar-based institute. It is one of the 12 centres selected by the ICMR for conducting phase one and two of the clinical trials. The human trials of BBV152 COVID Vaccine or Covaxin will begin on Wednesday in a special laboratory set up at the Institute of Medical Sciences and SUM (IMS & SUM) Hospital, in accordance with the protocols laid down by the Drugs Contro…
-
General16 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News22 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Noosa News20 hours agoMore children’s sand products from Kmart and Target recalled over asbestos contamination fears
-
Noosa News20 hours agoBurgess Creek to go weed free